Eaton Vance Management

SEC CIK: 0001076598
Latest filing: Nov 14, 2022

SEC filings (opens in a new tab)

SAGE holding history

Sage Therapeutics, Inc. in every 13F filed by Eaton Vance Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SAGE overview All 13F holders of SAGE Full Q3 2022 holdings

Shares (Q2 2021): 0; Sold out in Q2 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 1; Since Q1 2021

Holdings of SAGE by Eaton Vance Management, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2021	0	$0	0.0%	−404−100.0%	Sold out	Holders
Q1 2021	404	$30.0K	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.